Finance

Lists
002390:SHE
Guizhou Xinbang Pharmaceutical Co Ltd
CNÂ¥3.10
+0.32%
(+0.0100) 1D
Nov 4, 3:04:39 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002390...
Open
CNÂ¥3.09
High
CNÂ¥3.13
Low
CNÂ¥3.07
Mkt. cap
6.01B
Avg. vol.
25.92M
Volume
28.39M
Dividend
2.90%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Sep 29, 2026
P/E ratio
42.88
52-wk high
CNÂ¥4.15
52-wk low
CNÂ¥2.54
EPS
CNÂ¥0.07
Shares outstanding
1.94B
No. of employees
5K
Open
CNÂ¥3.09
High
CNÂ¥3.13
Low
CNÂ¥3.07
Mkt. cap
6.01B
Avg. vol.
25.92M
Volume
28.39M
Dividend
2.90%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Sep 29, 2026
P/E ratio
42.88
52-wk high
CNÂ¥4.15
52-wk low
CNÂ¥2.54
EPS
CNÂ¥0.07
Shares outstanding
1.94B
No. of employees
5K
News stories
From web sources and news partners
About Guizhou Xinbang Pharmaceutical Co Ltd
CEO-
Employees4.7K
FoundedJan 27, 1995
Headquarters-
SectorPharmaceutical industry
Industry-
Websitexinbang.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.35B
1.26B
1.20B
1.20B
Cost of goods sold
1.12B
1.06B
1.01B
966.72M
Cost of revenue
1.12B
1.06B
1.01B
966.72M
Research and development expenses
1.50M
1.95M
2.40M
1.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
153.22M
121.62M
114.72M
112.84M
Operating expense
181.58M
127.31M
129.01M
112.79M
Total operating expenses
1.30B
1.19B
1.14B
1.08B
Operating income
54.46M
77.38M
65.80M
115.62M
Other non operating income
-56.24M
259.61K
-5.96M
-7.03M
EBT including unusual items
4.74M
76.27M
77.46M
122.60M
EBT excluding unusual items
16.58M
76.18M
74.99M
125.67M
Income tax expense
13.72M
11.71M
5.89M
14.97M
Effective tax rate
289.59%
15.36%
7.61%
12.21%
Other operating expenses
10.40M
5.92M
7.90M
739.43K
Net income
-32.04M
48.66M
50.93M
70.83M
Net profit margin
-2.37%
3.85%
4.23%
5.93%
Earnings per share
-
-
-
-
Interest and investment income
20.59M
1.86M
18.18M
17.08M
Interest expense
-2.25M
-3.32M
-3.02M
-
Net interest expenses
18.35M
-1.45M
15.16M
17.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
102.75M
125.66M
112.94M
163.90M
Gain or loss from assets sale
3.48M
-
524.45K
-524.45K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps